{
Brian Johnson

People

}
gene therapy market poised for growth driven by innovation and collaboration
The global gene therapy market, valued at $7.54 billion in 2022, is projected to reach $41.38 billion by 2031, driven by increased R&D, favorable regulations, and collaborations between pharmaceutical companies and academic institutions. North America leads the market, with significant advancements in biotechnology and numerous clinical trials. Recent developments include Novartis's acquisition of a gene therapy candidate from Avrobio and Bristol-Myers Squibb's expansion of its cell therapy manufacturing network.
openPR.com
United States Dollar Novartis AG Bristol-Myers Squibb Co MEX CAN FRA IND KOR CHN ZAF DEU USA ITA GBR ESP JPN ARG BRA Brian Johnson Show more
Healthcare, Market Report
08:28 18.12.2024
Nanotechnology in Medicine and Healthcare Market Forecast and Growth Opportunities 2024 to 2031
The Nanotechnology in Medicine and Healthcare Market report provides a comprehensive analysis of market trends, growth opportunities, and competitive dynamics from 2024 to 2031. It covers key segments, including nanoparticles and drug delivery applications, while offering insights into major players like Abbott Laboratories and Johnson & Johnson. The report also includes a SWOT analysis and highlights regional consumption patterns, aiding stakeholders in strategic decision-making.
openPR.com
Merck & Co., Inc. Abbott Laboratories Johnson & Johnson Thermo Fisher Scientific Inc. ZAF EGY ARE NGA SAU Eddy Merckx Brian Johnson Show more
Technology & Innovation, Market Report
11:05 06.12.2024
Biocon shares surge after US FDA approves Yesintek biosimilar for treatment
Biocon shares surged over 4% following the U.S. FDA's approval of Yesintek, a biosimilar to J&J's Stelara, for treating Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. The stock has risen 47% year-to-date, outperforming the Nifty 50's 11% increase. This marks the seventh consecutive day of gains for Biocon, which has a licensing agreement with Janssen to commercialize Yesintek in the U.S. by February 2025.
Moneycontrol
United States Dollar Biocon Limited Johnson & Johnson USA IND Brian Johnson
Healthcare, Market Report
08:00 02.12.2024
healthcare consumables market poised for rapid growth driven by sustainability trends
The healthcare consumables market is projected to grow from $281.63 billion in 2023 to $466.65 billion by 2028, driven by rising hospital admissions, chronic disease prevalence, and the adoption of biodegradable products. Major players are focusing on eco-friendly innovations to enhance sustainability and meet increasing healthcare demands.
openPR.com
Nipro Corporation Medi-Plast Ltd. Fresenius Kabi AG Smith & Nephew plc Alcon Laboratories Inc. B. Braun Melsungen AG Zimmer Biomet Holdings, Inc. Invacare Corporation BioLife Solutions, Inc. Boston Scientific Corporation Johnson & Johnson Siemens Healthineers AG Abbott Laboratories Cardinal Health, Inc. GE HealthCare Technologies Inc. Coloplast A/S Philips Healthcare DexCom, Inc. Ortho-Clinical Diagnostics Inc. Terumo Corporation AngioDynamics, Inc. Becton Dickinson and Company (BD) Stryker Corporation Hollister Incorporated Hologic, Inc. 3M Company Brian Johnson Show more
Healthcare, Market Report
11:38 28.11.2024
AstraZeneca's Enhertu approved for reimbursement in China amid ongoing probe
AstraZeneca’s Enhertu, a leading breast cancer treatment, has been approved for reimbursement by China’s state-run medical insurance, enhancing the company’s sales prospects amid an ongoing investigation involving some senior executives. The drug is one of 91 added to the National Reimbursement Drug List, effective January 1, alongside treatments from Johnson & Johnson, Bristol Myers Squibb, Roche, Sanofi, and Merck for various conditions.
Bloomberg.com
United States Dollar Sanofi Merck & Co., Inc. Bristol-Myers Squibb Company Roche Holding AG AstraZeneca PLC Johnson & Johnson GBR Brian Johnson Show more
Healthcare, News Article
08:22 28.11.2024
consumer healthcare market poised for rapid growth driven by digital innovations
The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
EIN News
United States Dollar Perrigo Company plc Cardinal Health, Inc. Johnson & Johnson Church & Dwight Co., Inc. Herbalife Nutrition Ltd. Nestlé S.A. Abbott Laboratories Teva Pharmaceutical Industries Ltd. AstraZeneca PLC DSM Nutritional Products AG Pfizer Inc. Colgate-Palmolive Company AbbVie Inc. Bayer AG BASF SE Glaxosmithkline plc Novartis International AG CVS Health Corporation Boehringer Ingelheim International GmbH Sanofi Amway Corporation Novo Nordisk A/S Ipsen S.A. Bristol-Myers Squibb Company McKesson Corporation Merck & Co., Inc. The Clorox Company Reckitt Benckiser Group plc Cigna Corporation Eli Lilly and Company Brian Johnson Show more
Healthcare, Market Report
00:30 27.11.2024
hi-tech medical devices market poised for growth driven by innovation and sustainability
The global Hi-Tech Medical Devices Market is experiencing significant growth driven by technological advancements, changing consumer preferences, and a focus on sustainability. Key objectives include forecasting market size across regions, analyzing growth factors, and identifying opportunities for stakeholders. Major players in the market include Medtronic, Abbott Laboratories, and Johnson & Johnson, with a comprehensive analysis of competitive dynamics and market trends provided in the research report.
openPR.com
Medtronic Johnson & Johnson Philips Healthcare Siemens Healthineers AG Baxter International Inc. Abbott Laboratories Edwards Lifesciences Corporation Hologic, Inc. DexCom, Inc. Fresenius Medical Care AG Thermo Fisher Scientific Inc. Becton, Dickinson and Company Varian Medical Systems Boston Scientific Corporation Zimmer Biomet Holdings, Inc. Intuitive Surgical, Inc. Illumina, Inc. St. Jude Medical, Atrial Fibrillation Division Inc. Stryker Corporation GE HealthCare Technologies Inc. USA DEU ITA MEX ARG AUS ZAF IND SAU RUS JPN KOR BRA CAN ARE ESP CHN Brian Johnson Jeff Stryker Show more
Technology & Innovation, Market Report
05:10 26.11.2024
healthcare oem manufacturers market projected to reach 382 billion by 2032
The Healthcare OEM Manufacturers Market is projected to grow from USD 198.59 billion in 2023 to USD 382.10 billion by 2032, with a CAGR of 9.8%. Key players include Johnson & Johnson, G.E. Healthcare, and Siemens Healthcare, driven by rising R&D spending and technological advancements. The market faces challenges such as stringent regulatory compliance and product safety concerns.
openPR.com
United States Dollar Aramark G.E. Healthcare Hitachi Medical Systems America Inc. Johnson & Johnson Esaote SpA Drägerwerk AG & Co. KGaA Koninklijke Philips N.V. Baxter International Inc. FUJIFILM Holdings Corporation Siemens Healthcare GmbH Toshiba Medical Systems Corporation USA DEU ITA FRA AUS IND SAU SGP POL ISR JPN KOR GBR ARE BEL TUR ESP NLD CHN AUT Brian Johnson Show more
Healthcare, Market Report
14:23 22.11.2024
healthcare sector anticipates surge in ipos and mergers by 2025
The healthcare sector is poised for a surge in IPOs and mergers by 2025, driven by optimism from executives despite geopolitical tensions being cited as the primary risk. Major deals, such as Johnson & Johnson's $13.1 billion acquisition of Shockwave Medical, underscore this growth, with 72% of professionals anticipating increased M&A activity, particularly in Europe. Additionally, nearly two-thirds expect a rise in healthcare IPOs, indicating a revitalized equity capital market.
Finimize
United States Dollar Johnson & Johnson Novo Nordisk A/S USA CHN Brian Johnson
Finance & Economy, Market Report
17:39 19.11.2024
global consumer health market projected to reach over 713 billion by 2033
The global consumer healthcare market is segmented by product types, including OTC pharmaceuticals, personal care products, and dietary supplements, with offline distribution channels expected to dominate. North America is projected to lead the market due to rising awareness of wellness products, while Asia Pacific is anticipated to grow rapidly, driven by increasing disposable incomes and a large elderly population. Key players include Johnson & Johnson, Procter and Gamble, and Pfizer, among others, with ongoing developments enhancing market dynamics.
Spherical Insights
United States Dollar Johnson & Johnson Colgate-Palmolive Company Bayer AG Merck & Co., Inc. Boehringer Ingelheim GmbH Nestlé S.A. Mylan N.V. Reckitt Benckiser Group plc Novartis International AG Glaxosmithkline plc Eli Lilly and Company Perrigo Company plc Sanofi Teva Pharmaceutical Industries Ltd. Abbott Laboratories Pfizer Inc. Procter and Gamble ESP IND QAT GBR JPN KOR AUS ARE CHN DEU USA BRA RUS MEX CAN ARG ITA SAU ZAF Brian Johnson Mylan Nv Show more
Healthcare, Market Report
18:35 18.11.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Central Bank Actions Banking Regulations Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Mergers & Acquisitions Cryptocurrency & Blockchain Regulations Cryptocurrency Developments Blockchain Technology Adoption Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Emerging Startups Cryptocurrency Regulations Inflation Rates & CPI Data SEC & Financial Compliance Banking & Investment Regulations
Countries:
USA CHE GBR DEU ARE HKG AUS JPN CHN IND SGP DNK CAN NGA FIN COL AUT VGB LIE TUR
Companies:
Credit Suisse Real Estate Fund Siat BlackRock, Inc. Coinbase Global, Inc. Solana USD Ethereum USD Ripples USD Tesla, Inc. Fidelity Contrafund Cardano USD Apple Inc. NVIDIA Corporation Grayscale Litecoin Trust Chainlink USD Tether USDt CNY Google Inc. Amazon.com, Inc. MicroStrategy Inc End Federal Reserve USD MicroStrategy Incorporated Crypto.com Staked ETH USD
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Indian Rupee Canadian Dollar Mozambican Metical British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Michael J. Saylor Thomas Jordan Gary Gensler Colm Kelleher Alan Santana Paul Atkins Joe Rogan Martin Schlegel Isabelle Chassot Mario Nawfal Paolo Ardoino Sergio Ermotti Dana White Joe Biden

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.